SCHEMBL13304520

SCHEMBL13304520

O=C(O)c1cnc(N2CCOC(Cn3ccn(-c4ccccc4)c3=O)C2)nc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC6 Q9UBN7 2/20 0.43
POLB P06746 1/20 0.43
HDAC3 O15379 1/20 0.43
HDAC4 P56524 1/20 0.43
HDAC1 Q13547 1/20 0.43
HDAC7 Q8WUI4 1/20 0.43
HDAC2 Q92769 1/20 0.43
HDAC10 Q969S8 1/20 0.43
HDAC11 Q96DB2 1/20 0.43
HDAC8 Q9BY41 1/20 0.43
HDAC9 Q9UKV0 1/20 0.43
HDAC5 Q9UQL6 1/20 0.43
MET P08581 7/20 0.37
AOC3 Q16853 1/20 0.37
MAPK8 P45983 1/20 0.36
CHRM4 P08173 1/20 0.36
RBP4 P02753 1/20 0.35
ALKBH1 Q13686 1/20 0.35
KCNA5 P22460 1/20 0.34
PIK3CD O00329 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13304567 0.91 HDAC6 (0.54) HDAC6HDAC3HDAC4HDAC1HDAC7
SCHEMBL13304518 0.89 HDAC6 (0.39) HDAC6HDAC3HDAC4HDAC1HDAC7
SCHEMBL13304521 0.83 HDAC6 (0.40) HDAC6HDAC3HDAC4HDAC1HDAC7
SCHEMBL13304584 0.82 HDAC6 (0.47) HDAC6HDAC3HDAC4HDAC1HDAC7
SCHEMBL13304585 0.82 HDAC6 (0.47) HDAC6HDAC3HDAC4HDAC1HDAC7
SCHEMBL13304577 0.81 HDAC6 (0.46) HDAC6HDAC3HDAC4HDAC1HDAC7
SCHEMBL13304583 0.81 HDAC6 (0.46) HDAC6HDAC3HDAC4HDAC1HDAC7
SCHEMBL13304578 0.81 HDAC1 (0.45) HDAC6HDAC3HDAC4HDAC1HDAC7
SCHEMBL13304581 0.80 HDAC1 (0.48) HDAC6HDAC3HDAC4HDAC1HDAC7
SCHEMBL13304582 0.80 HDAC6 (0.45) HDAC6HDAC3HDAC4HDAC1HDAC7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100160321-A1 IMIDAZOLINONE AND HYDANTOINE DERIVATIVES AS NOVEL INHIBITORS OF HISTONE DEACETYLASE JANSSEN PHARMACEUTICA N.V. (BE) 2010-06-24 US disclosed
US-20100160321-A1 IMIDAZOLINONE AND HYDANTOINE DERIVATIVES AS NOVEL INHIBITORS OF HISTONE DEACETYLASE JANSSEN PHARMACEUTICA N.V. (BE) 2010-06-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100160321-A1 IMIDAZOLINONE AND HYDANTOINE DERIVATIVES AS NOVEL INHIBITORS OF HISTONE DEACETYLASE HDAC1, HDAC2, HDAC3 HDAC6 11/4885POLB 1922/4885HDAC3 3/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.